FindTrial
Sign In

FDG-PET/CT

DIAGNOSTIC_TEST15 trials

Sponsors

Division of Rheumatic Diseases, National Center for Global Health and Medicine, The University of Osaka, Washington University School of Medicine, University of Utah, Jonsson Comprehensive Cancer Center

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaCarcinoma, Squamous CellCervical CancerCoronavirus InfectionExtrapulmonary Tuberculosis in HIV PatientsFebrile NeutropeniaHaematopoietic Stem Cell Transplant, Allogeneic

Early Phase 1

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
CompletedNCT01894451
Dana-Farber Cancer InstituteInflammatory Breast Carcinoma
Start: 2015-06-30End: 2017-03-17Updated: 2019-12-12

Phase 1

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
TerminatedNCT02317302
Washington University School of MedicineCervical Cancer, Uterine Cervical Cancer, Uterine Cervical Neoplasms
Start: 2011-06-28End: 2020-06-02Updated: 2020-06-11

Phase 2

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
CompletedNCT00671437
Washington University School of MedicineCarcinoma, Squamous Cell
Start: 2008-06-30End: 2015-08-31Updated: 2017-03-14

Unknown Phase

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism
CompletedNCT01107327
University of UtahVenothromboembolism
Start: 2006-08-31End: 2012-01-31Updated: 2014-10-31
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
CompletedNCT01410630
Jonsson Comprehensive Cancer CenterLarge B Cell Diffuse Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin
Start: 2017-09-07End: 2019-10-04Updated: 2021-05-11
Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma
NCT02089204
Xuzhou Medical UniversityNasopharyngeal Carcinoma
Start: 2010-06-30End: 2015-12-31Target: 300Updated: 2014-03-17
FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)
CompletedNCT02208544
Radboud University Medical CenterThyroid Neoplasms, Thyroid Nodule
Start: 2015-07-16End: 2022-02-15Updated: 2022-05-04
PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial
CompletedNCT02822014
Centre Hospitalier Universitaire Saint PierreExtrapulmonary Tuberculosis in HIV Patients
Start: 2010-02-28End: 2015-06-30Updated: 2016-07-04
Clinical value of whole-body PET/CT in patients with active rheumatic diseases.
RecruitingJPRN-UMIN000022735
Division of Rheumatic Diseases, National Center for Global Health and MedicineRheumatic diseases
Start: 2016-09-01Target: 100Updated: 2026-06-29
Molecular Evaluation in Metastatic Breast Cancer
NCT03358589
Odense University HospitalMetastatic Breast Cancer, Molecular Imaging
Start: 2017-09-01End: 2021-08-31Target: 270Updated: 2021-05-25
PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
CompletedNCT03429387
Peter MacCallum Cancer Centre, AustraliaAcute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Febrile Neutropenia +2
Start: 2018-01-08End: 2021-01-23Updated: 2022-05-17
COvid iMaging With POSitron Emission Tomography
NCT05009563
Semmelweis University Heart and Vascular CenterCoronavirus Infection
Start: 2021-01-04End: 2022-01-04Target: 50Updated: 2021-08-17
the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis
Active, not recruitingNCT05291468
St. Antonius HospitalSarcoidosis, Pulmonary, Sarcoidosis Skin
Start: 2023-02-15End: 2026-12-01Target: 40Updated: 2026-02-12
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
RecruitingNCT06877949
Odense University HospitalMetastatic Breast Cancer, Response Monitoring
Start: 2025-04-02End: 2029-04-01Target: 420Updated: 2026-02-20
A Study on the Clinical Features of Metastatic Castration-Resistant Prostate Cancer Using PSMA-PET and FDG-PET
Active, not recruitingJPRN-UMIN000060979
The University of OsakaMetastatic Castration-Resistant Prostate Cancer
Start: 2026-04-01Target: 100Updated: 2026-06-29

Related Papers

Evaluating the cost-effectiveness of [<sup>18</sup>F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients.
2023-12-151 citations
Molecular Diagnostics and [ <sup>18</sup> F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?
Thyroid2023-11-2711 citations
2-[<sup>18</sup>F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.
2023-04-0513 citations
[<sup>18</sup>F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
2022-10-178 citations
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.
2022-06-2819 citations
Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
Endocrine Connections2022-06-227 citations
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
European Journal of Nuclear Medicine and Molecular Imaging2022-04-1821 citations
Quantitative classification and radiomics of [<sup>18</sup>F]FDG-PET/CT in indeterminate thyroid nodules.
2022-02-0924 citations
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
European Journal of Nuclear Medicine and Molecular Imaging2022-01-0442 citations
Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study.
2021-09-2220 citations
A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma
UNC Libraries2020-11-074 citations
Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
Research Involvement and Engagement2020-01-0642 citations
Abstract OT2-02-03: Pilot study of zirconium-89 bevacizumab positron emission tomography for imaging angiogenesis in patients with inflammatory breast carcinoma receiving preoperative chemotherapy
Cancer Research2017-02-15
A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma
PLoS ONE2015-04-2744 citations